These medications should also be used cautiously in individuals with certain medical conditions, such as epilepsy, untreated hypothyroidism, obesity, hyperglycemia, or elevated levels of plasma fatty acids, as these conditions may increase the risk of adverse effects or alter the drugs response
Conclusion This study demonstrates that adjunctive semaglutide therapy with intragastric balloon (IGB) enhances both the magnitude of short-term weight loss, while enhancing the sustainability achieved with intragastric ballooning alone
It may, however, take up to 12 weeks to see the full effects
Whether seeking a semaglutide prescription online for the first time or considering switching from compounded products to FDA-approved branded medications, Klinic connects you with skilled GLP-1 providers who tailor personalized treatment plans